共 107 条
[1]
Klunk WE(2004)Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B Ann Neurol 55 306-19
[2]
Engler H(2002)Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease Am J Geriatr Psychiatry 10 24-35
[3]
Nordberg A(2004)In-vivo imaging of Alzheimer disease beta-amyloid with [11C]SB-13 PET Am J Geriatr Psychiatry 12 584-95
[4]
Shoghi-Jadid K(2008)Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease Brain 131 1630-45
[5]
Small GW(2008)Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B Arch Neurol 65 1304-9
[6]
Agdeppa ED(2011)In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults Arch Neurol 68 232-40
[7]
Verhoeff NP(2007)Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer’s disease enabled by positron emission tomography J Neurosci 27 10957-68
[8]
Wilson AA(2012)Small-animal PET imaging of amyloid-beta plaques with [C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer’s disease PLoS One 7 e31310-606
[9]
Takeshita S(2005)Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer’s disease brain but not in transgenic mouse brain J Neurosci 25 10598-600
[10]
Ikonomovic MD(2005)PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer’s disease Eur J Nucl Med Mol Imaging 32 593-56